Evaluating health related quality of life in outpatients receiving anti-cancer treatment: results from an observational, cross-sectional study.

Hae-Jin Suh OhÁngeles Flórez MenéndezVíctor Sacristán SantosÁngeles Rodríguez MartínezFrancisca Fernández RibeiroLucía Vilanova-TrilloManuel Constenla FigueirasManuel Pereiro Ferreiros

Published in: Health and quality of life outcomes (2021)

In our study, the neoplastic disease and anti-cancer treatment toxicities had an impact on HRQOL. Patients had poorer scores in the functional well-being domain and higher ones in the social/family well-being domain. Variables associated with worse HRQOL were tumor stage, performance status (ECOG) and female sex.

Keyphrases

ejection fraction
newly diagnosed
prognostic factors
combination therapy
cross sectional
smoking cessation